Imatinib prevents beta cell death in vitro but does not improve islet transplantation outcome

Introduction Improving islet transplantation outcome could not only bring benefits to individual patients but also widen the patient pool to which this life-changing treatment is available. Imatinib has previously been shown to protect beta cells from apoptosis in a variety of in vitro and in vivo m...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Aileen J. F., Griffiths, Lisa A., Persaud, Shanta J., Jones, Peter M., Howell, Simon L., Welsh, Nils
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900069/
https://www.ncbi.nlm.nih.gov/pubmed/26953716
http://dx.doi.org/10.3109/03009734.2016.1151090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900069/
https://www.ncbi.nlm.nih.gov/pubmed/26953716
http://dx.doi.org/10.3109/03009734.2016.1151090

Ejemplares similares